Comment on biochemical response to ursodeoxycholic acid and long‐term prognosis in primary biliary cirrhosis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2009-01, Vol.49 (1), p.337-338
Hauptverfasser:	Walker, Lucy J., Newton, Julia, Jones, David E. J., Bassendine, Margaret F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Alkaline Phosphatase - blood Bezafibrate - therapeutic use Cholagogues and Choleretics - therapeutic use Drug Synergism Fenofibrate - therapeutic use Humans Immunoglobulin M - blood Liver Cirrhosis, Biliary - drug therapy Prognosis Ursodeoxycholic Acid - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	338
container_issue	1
container_start_page	337
container_title	Hepatology (Baltimore, Md.)
container_volume	49
creator	Walker, Lucy J. Newton, Julia Jones, David E. J. Bassendine, Margaret F.
description
doi_str_mv	10.1002/hep.22670
format	Article
fullrecord	<record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_hep_22670</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HEP22670</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3580-bc78d65da4d94ba35362575b869d332f46b17df41215b593c150b2a088497cc93</originalsourceid><addsrcrecordid>eNp1kMtKw0AYhQdRbKwufAGZrYu0c8kkmaWUaoWCLnQd5pZmJJkJMy3anY_gM_okpqbgytXh5_84HD4ArjGaYYTIvDH9jJC8QCcgwYwUKaUMnYIEkQKlHFM-ARcxviGEeEbKczDBHFFGM5IAt_BdZ9wWegel9aoxnVWihcHE3rto4NbDXYheG_-xV41vrYJCWQ2F07D1bvP9-bU1oYN98Bvno43QuuGwnQj7obG1h1Q2hObwvARntWijuTrmFLzeL18Wq3T99PC4uFunirISpVIVpc6ZFpnmmRTD1pywgsky55pSUme5xIWuM0wwk4xThRmSRKCyzHihFKdTcDv2quBjDKaujpMqjKqDs2pwVv06G9ibke13sjP6jzxKGoD5CLzb1uz_b6pWy-ex8gcPWXiB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comment on biochemical response to ursodeoxycholic acid and long‐term prognosis in primary biliary cirrhosis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><creator>Walker, Lucy J. ; Newton, Julia ; Jones, David E. J. ; Bassendine, Margaret F.</creator><creatorcontrib>Walker, Lucy J. ; Newton, Julia ; Jones, David E. J. ; Bassendine, Margaret F.</creatorcontrib><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1002/hep.22670</identifier><identifier>PMID: 19035342</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Alkaline Phosphatase - blood ; Bezafibrate - therapeutic use ; Cholagogues and Choleretics - therapeutic use ; Drug Synergism ; Fenofibrate - therapeutic use ; Humans ; Immunoglobulin M - blood ; Liver Cirrhosis, Biliary - drug therapy ; Prognosis ; Ursodeoxycholic Acid - therapeutic use</subject><ispartof>Hepatology (Baltimore, Md.), 2009-01, Vol.49 (1), p.337-338</ispartof><rights>Copyright © 2008 American Association for the Study of Liver Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3580-bc78d65da4d94ba35362575b869d332f46b17df41215b593c150b2a088497cc93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhep.22670$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhep.22670$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27931,27932,45581,45582</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19035342$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walker, Lucy J.</creatorcontrib><creatorcontrib>Newton, Julia</creatorcontrib><creatorcontrib>Jones, David E. J.</creatorcontrib><creatorcontrib>Bassendine, Margaret F.</creatorcontrib><title>Comment on biochemical response to ursodeoxycholic acid and long‐term prognosis in primary biliary cirrhosis</title><title>Hepatology (Baltimore, Md.)</title><addtitle>Hepatology</addtitle><subject>Alkaline Phosphatase - blood</subject><subject>Bezafibrate - therapeutic use</subject><subject>Cholagogues and Choleretics - therapeutic use</subject><subject>Drug Synergism</subject><subject>Fenofibrate - therapeutic use</subject><subject>Humans</subject><subject>Immunoglobulin M - blood</subject><subject>Liver Cirrhosis, Biliary - drug therapy</subject><subject>Prognosis</subject><subject>Ursodeoxycholic Acid - therapeutic use</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtKw0AYhQdRbKwufAGZrYu0c8kkmaWUaoWCLnQd5pZmJJkJMy3anY_gM_okpqbgytXh5_84HD4ArjGaYYTIvDH9jJC8QCcgwYwUKaUMnYIEkQKlHFM-ARcxviGEeEbKczDBHFFGM5IAt_BdZ9wWegel9aoxnVWihcHE3rto4NbDXYheG_-xV41vrYJCWQ2F07D1bvP9-bU1oYN98Bvno43QuuGwnQj7obG1h1Q2hObwvARntWijuTrmFLzeL18Wq3T99PC4uFunirISpVIVpc6ZFpnmmRTD1pywgsky55pSUme5xIWuM0wwk4xThRmSRKCyzHihFKdTcDv2quBjDKaujpMqjKqDs2pwVv06G9ibke13sjP6jzxKGoD5CLzb1uz_b6pWy-ex8gcPWXiB</recordid><startdate>200901</startdate><enddate>200901</enddate><creator>Walker, Lucy J.</creator><creator>Newton, Julia</creator><creator>Jones, David E. J.</creator><creator>Bassendine, Margaret F.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200901</creationdate><title>Comment on biochemical response to ursodeoxycholic acid and long‐term prognosis in primary biliary cirrhosis</title><author>Walker, Lucy J. ; Newton, Julia ; Jones, David E. J. ; Bassendine, Margaret F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3580-bc78d65da4d94ba35362575b869d332f46b17df41215b593c150b2a088497cc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Alkaline Phosphatase - blood</topic><topic>Bezafibrate - therapeutic use</topic><topic>Cholagogues and Choleretics - therapeutic use</topic><topic>Drug Synergism</topic><topic>Fenofibrate - therapeutic use</topic><topic>Humans</topic><topic>Immunoglobulin M - blood</topic><topic>Liver Cirrhosis, Biliary - drug therapy</topic><topic>Prognosis</topic><topic>Ursodeoxycholic Acid - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walker, Lucy J.</creatorcontrib><creatorcontrib>Newton, Julia</creatorcontrib><creatorcontrib>Jones, David E. J.</creatorcontrib><creatorcontrib>Bassendine, Margaret F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walker, Lucy J.</au><au>Newton, Julia</au><au>Jones, David E. J.</au><au>Bassendine, Margaret F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comment on biochemical response to ursodeoxycholic acid and long‐term prognosis in primary biliary cirrhosis</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><addtitle>Hepatology</addtitle><date>2009-01</date><risdate>2009</risdate><volume>49</volume><issue>1</issue><spage>337</spage><epage>338</epage><pages>337-338</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>19035342</pmid><doi>10.1002/hep.22670</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0270-9139
ispartof	Hepatology (Baltimore, Md.), 2009-01, Vol.49 (1), p.337-338
issn	0270-9139 1527-3350
language	eng
recordid	cdi_crossref_primary_10_1002_hep_22670
source	MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library
subjects	Alkaline Phosphatase - blood Bezafibrate - therapeutic use Cholagogues and Choleretics - therapeutic use Drug Synergism Fenofibrate - therapeutic use Humans Immunoglobulin M - blood Liver Cirrhosis, Biliary - drug therapy Prognosis Ursodeoxycholic Acid - therapeutic use
title	Comment on biochemical response to ursodeoxycholic acid and long‐term prognosis in primary biliary cirrhosis
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-08T21%3A02%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comment%20on%20biochemical%20response%20to%20ursodeoxycholic%20acid%20and%20long%E2%80%90term%20prognosis%20in%20primary%20biliary%20cirrhosis&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=Walker,%20Lucy%20J.&rft.date=2009-01&rft.volume=49&rft.issue=1&rft.spage=337&rft.epage=338&rft.pages=337-338&rft.issn=0270-9139&rft.eissn=1527-3350&rft_id=info:doi/10.1002/hep.22670&rft_dat=%3Cwiley_cross%3EHEP22670%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19035342&rfr_iscdi=true